Third Point
DHR · Medicine & biotech

Danaher

Makes lab tools and tests used by scientists and drug makers.
Bought more
Third Point owns 540,000 shares of Danaher, worth about $103 million. That’s $2 of every $100 they have in stocks. Between April and June they bought 15,000 more (up 3%).
Mar 31
525,000
Jun 30
540,000

The numbers

Shares they own
540,000
Change since Mar 31
+15,000
+2.9%
Shares on Mar 31
525,000
Value on Jun 30, 2026
$102,859,200
about $103 million
Share of their money
2.3%
$2 of every $100 · 19th of 35
Price per share on Jun 30
$190.48
Cost of the shares they added
about $3 million
at the Jun 30 price
Kind
Shares
More about Danaher
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works